SCHEMBL8348366

SCHEMBL8348366

COc1cccc(CNC(=O)c2cc(C(=O)NCc3ccnc(OC)c3)ncn2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 6/20 0.61
PRKACA P17612 2/20 0.54
PRKX P51817 2/20 0.54
PRKCQ Q04759 2/20 0.54
ROCK1 Q13464 2/20 0.54
ROCK2 O75116 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
GSK3A P49840 1/20 0.54
GSK3B P49841 1/20 0.54
CLK4 Q9HAZ1 1/20 0.54
HPGD P15428 3/20 0.53
KMT2A Q03164 1/20 0.53
GRK5 P34947 1/20 0.53
KDM4E B2RXH2 2/20 0.53
HSD17B10 Q99714 1/20 0.53
AURKA O14965 1/20 0.52
ALDH1A1 P00352 2/20 0.51
USP2 O75604 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8358822 0.91 MMP13 (0.69) MMP13PRKACAPRKXPRKCQROCK1
SCHEMBL8348717 0.89 ROCK1 (0.65) MMP13PRKACAPRKXPRKCQROCK1
SCHEMBL8348510 0.88 MMP13 (0.57) MMP13PRKACAPRKXPRKCQROCK1
SCHEMBL5615864 0.86 MMP13 (0.63) MMP13PRKACAPRKXPRKCQROCK1
SCHEMBL4720432 0.86 MMP13 (0.63) MMP13PRKACAPRKXPRKCQROCK1
SCHEMBL8350620 0.85 MMP13 (0.62) MMP13PRKACAPRKXPRKCQROCK1
SCHEMBL5615621 0.84 MMP13 (0.76) MMP13PRKACAPRKXPRKCQROCK1
SCHEMBL8348605 0.84 MMP13 (0.60) MMP13PRKACAPRKXPRKCQROCK1
SCHEMBL4715297 0.84 ROCK2 (0.71) MMP13PRKACAPRKXPRKCQROCK1
SCHEMBL8338462 0.83 ROCK1 (0.58) MMP13PRKACAPRKXPRKCQROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004060883-A1 PYRIMIDINE-4,6-DICARBOXYLIC ACID DIAMIDES FOR USE AS SELECTIVE MMP 13 INHIBITORS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-07-22 WO disclosed